Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 722,052 | 372,268 | 2,628,501 | 2,015,459 | 1,651,594 |
| Depreciation Amortization | 842,300 | 411,587 | 856,044 | 620,902 | 423,654 |
| Income taxes - deferred | 26,905 | 61,288 | 105,311 | 80,129 | 3,406 |
| Accounts receivable | -197,414 | -491,253 | -201,349 | -293,959 | -508,921 |
| Accounts payable and accrued liabilities | 2,302 | 62,287 | 5,291 | 52,019 | 39,735 |
| Other Working Capital | -266,117 | -667,697 | 543,867 | -244,309 | 18,781 |
| Other Operating Activity | -87,179 | 337,340 | -1,502,549 | -811,413 | -899,767 |
| Operating Cash Flow | $1,042,849 | $85,820 | $2,435,117 | $1,418,828 | $728,483 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -553,609 | -225,954 | -1,184,244 | -816,778 | -531,273 |
| Net Acquisitions | -2,135,345 | -2,064,331 | 894,853 | 1,166,173 | 1,570,552 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1 |
| Investing Cash Flow | $-2,688,954 | $-2,290,285 | $-289,391 | $349,395 | $1,039,278 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 320,679 | 106,208 | 1,025,439 | -142,281 | 364,785 |
| Debt Issued | 1,431,718 | 470,741 | 723,230 | 727,326 | 132,598 |
| Debt Repayment | -328,699 | -19,787 | -1,270,997 | 709,614 | -299,228 |
| Common Stock Issued | 11,899 | 168 | 55,984 | -343,688 | 6,964 |
| Common Stock Repurchased | -336,052 | -101,593 | -43,958 | 51,674 | -44,390 |
| Dividend Paid | -398,611 | N/A | -383,634 | -377,689 | -387,402 |
| Other Financing Activity | -450,742 | 364,487 | -911,195 | -1,478,578 | -709,903 |
| Financing Cash Flow | $250,191 | $820,225 | $-805,130 | $-853,622 | $-936,576 |
| Exchange Rate Effect | 20,666 | 36,223 | 38,249 | -12,412 | -20,990 |
| Beginning Cash Position | 2,411,690 | 2,437,009 | 1,155,147 | 1,137,247 | 1,166,493 |
| End Cash Position | 1,036,443 | 1,088,991 | 2,533,991 | 2,039,436 | 1,976,688 |
| Net Cash Flow | $-1,375,248 | $-1,348,017 | $1,378,845 | $902,189 | $810,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,042,849 | 85,820 | 2,435,117 | 1,418,828 | 728,483 |
| Capital Expenditure | -558,694 | -228,124 | -1,248,643 | -851,049 | -555,640 |
| Free Cash Flow | 484,155 | -142,304 | 1,186,474 | 567,779 | 172,844 |